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SATU KAJIAN BERSAMA PENGGUNA AMPHETAMINE TYPE STIMULANT 
(ATS) DI NEGERI-NEGERI TERPILIH DI MALAYSIA  
 
ABSTRAK 
Terdapat peningkatan yang ketara dalam bilangan orang yang menggunakan 
Amphetamine type Stimulants (ATS) di Malaysia sejak beberapa tahun yang  lalu.  Data 
yang sedia ada hanya merujuk kepada bilangan pengguna ATS yang ditangkap serta 
rampasan ATS oleh agensi-agensi penguatkuasa. Terdapat keperluan untuk memahami 
konteks penggunaannya oleh pengguna. Oleh itu kajian ini bertujuan untuk mengenal 
pasti ciri sosio-demografi pengguna ATS, untuk memahami konteks penggunaan dadah 
di kalangan pengguna dadah ATS, untuk mengenal pasti tingkah laku seksual mereka 
dan juga untuk menentukan beberapa masalah kesihatan yang dikaitkan dengan 
penggunaan ATS di Malaysia. Satu kajian keratan rentas telah dijalankan bersama  118 
pengguna utama ATS di negeri  Pulau Pinang, Kuala Lumpur, Selangor dan Johor 
Baharu. Teknik persampelan bertujuan telah digunakan untuk  merekrut subjek kajian 
dan soal selidik digunakan sebagai instrumen kajian bagi mengumpul data. Ujian 
saringan air kencing bagi dadah jenis opioid, methadon, bezodiazepine, ketamin, 
methampetamine, amphetamine dan ganja telah dijalankan bertujuan bagi menentukan 
status pengguna dadah serta untuk mengesahkan maklumat  laporan sendiri penggunaan 
dadah subjek kajian. Statistik deskriptif dan ujian Pearson’s chi-square telah di gunakan 
bagi mengesahkan hubungan signifikan antara dua kumpulan. Ciri sosio-demografi  
subjek kajian adalah seperti berikut: min umur 33.1; 81% lelaki, 9% perempuan 
manakala 10% transgender; 71% Melayu, Cina 22%; India 7%; kebanyakan bekerja; 
xiii 
 
majoriti menerima pendidikan selama sembilan hingga sebelas tahun; 61% tidak 
berkahwin. Terdapat dua kumpulan pengguna dadah yang berbeza. Kumpulan yang 
pertama terdiri daripada mereka yang hanya menggunakan dadah ATS sahaja, manakala 
kumpulan yang kedua menggunakan dadah ATS bersama dadah-dadah lain. Hampir 
separuh daripada mereka telah menggunakan dadah ATS lebih dari 5 tahun, kebanyakan 
daripada mereka juga dilaporkan menggunakan dadah ATS satu hingga dua kali sahaja 
dalam seminggu. Perkara ini seterusnya disahkan melalui analisa sekunder dimana tiada 
perbezaan diantara  pengguna jangka pendek dan pengguna jangka panjang. Kebanyakan 
pengguna dadah ATS melaporkan bahawa mereka menggunakan ATS dengan cara 
menghisap/menyedut dan penyuntikan ATS agak rendah dengan 10%. Kadar jangkitan 
HIV dalam kajian ini adalah 7%. Peratusan tinggi daripada subjek kajian  melaporkan 
bahawa mereka terlibat baru-baru ini (30 hari) dalam tingkah laku jenayah.  Satu perlima 
daripada mereka masih aktif dalam seks dimana mereka dilaporkan mempunyai lebih 
dari satu pasangan seks dalam tempoh 30 hari yang lalu. Penggunaan kondom juga 
rendah dimana sebanyak 17%  daripada mereka tidak menggunakan kondom bersama  
pasangan kasual dan pekerja seks. Analisa sekunder juga menunjukkan bahawa yang 
menggunakan ATS hanya menggunakan dadah ATS sahaja mempunyai kecenderungan 
tinggi untuk menjadi aktif secara seksual  berbanding mereka yang menggunakan dadah 
lain. Lebih daripada suku subjek kajian dilaporkan mengalami sedikit masalah kesihatan 
disebabkan penggunaan ATS dan tiga perempat melaporkan mengalami masalah 
psikologikal. Kumpulan pengguna ATS sahaja dilaporkan untuk mempunyai 
kemungkinan yang tinggi untuk mengalami halusinasi dan ia lebih jelas dikalangan 
penguna jangka panjang dimana mereka dilaporkan mengalami kelemahan fizikal. 
Masalah kesihatan lain yang dilaporkan adalah masalah insomnia. Kebanyakan daripada 
xiv 
 
responden juga dilaporkan mengalami keinginan yang tinggi untuk menggunakan ATS. 
Kajian ini telah menyumbang kepada kefahaman siapa pengguna dadah ATS ini 
sebenarnya, bagaimana dadah ini digunakan dan juga sedikit masalah kesihatan yang 
dialami disebabkan penggunaan dadah ATS. Data kajian ini memberikan kefahaman 
yang lebih baik terhadap masalah ini jika dibandingkan dengan sebelum ini hanya 
terdapat data rampasan dan tangkapan sahaja. 
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A STUDY ON AMPHETAMINE TYPE STIMULANT (ATS) USERS IN 
SELECTED STATES IN MALAYSIA 
 
ABSTRACT 
There has been a tremendous increase in the number of people using 
Amphetamine Type Stimulants (ATS) in Malaysia over the last several years. The 
current data available is only on the number of ATS users arrested and seizure of ATS 
by enforcement agencies. There is a need to understand the context of its use by these 
users. Therefore the study aimed to identify the socio-demographic characteristics of 
ATS users, to understand the context of drug use among ATS drug users, to identify 
their sexual behaviors and to determine some of the medical health problems linked to 
ATS use in selected states in Malaysia. A cross-sectional survey was conducted among 
118 primary ATS users in Penang, Kuala Lumpur, Selangor and Johor Bahru. A 
purposive sampling technique was used to recruit study participants and a questionnaire 
was used as the survey instrument to collect data.  Urine toxicology screen for opiates, 
methadone, benzodiazepines, ketamine, methamphetamine, amphetamine and cannabis 
was conducted to objectively determine the drug use status and also to validate the self-
report of current drug user data. Descriptive statistics and Pearson’s chi square test was 
conducted to determine the significance between the two groups. The socio-
demographic characteristics of the patients are as follows; mean age 33.1 years, 81% 
males, 9% females and 10% transgender; 71% Malay, Chinese 22%, Indian 7%; mostly 
employed and majority had nine to eleven years of education, 61% single. There are two 
distinct groups of drug users. The first group consists of those who only use ATS drugs 
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and another group who use ATS together with other drugs. More than half of them have 
been using ATS for more than five years and most of them also report to use ATS only 
one to two days a week. This is further confirmed in the secondary analysis where there 
is no difference between short term and long term users. Most of the users reported that 
they use ATS by smoking/snorting it and injecting ATS is relatively low at 10%. HIV 
infection rate reported in this study is 7%. High percentage of respondents reported that 
they were involved in recent (30 days) criminal behavior. One fifth of them were 
sexually active where they reported to have more than one partner in the last 30 days. 
Condom use was also on the low side where a total of 17% of them did not use condom 
with a casual and sex worker. The secondary analysis also showed that those who only 
used ATS were more likely to be sexually more active than those who used other drugs. 
Slightly more than a quarter of the respondents reported to have experienced health 
problems related to ATS use while three quarter of them reported to have experienced 
some psychological problems. The ATS only group of respondents reported to have 
higher odds of experiencing hallucinations and it is more apparent with long-term use 
where they are also reported to experience physical weakness. The other health problems 
reported were insomnia. A high proportion of the respondents also reported to 
experience intense craving for ATS. This study has contributed to a better understanding 
of who are these ATS users, how the drugs are used and some of the health problems 
experienced as a result of ATS use. This data provides a better understanding to the 
problem compared to previously where only seizure and arrests related data was 
available. 
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CHAPTER 1 
 
INTRODUCTION 
1.0 Introduction 
The first chapter of the thesis will provide an introduction to the drug abuse 
problem in Malaysia and specifically discuss the problem of Amphetamine-Type-
Stimulant (ATS) use in the country. This will be followed by the research problem 
where the justification to conduct this study will be made. In this chapter, the 
research objectives of the study, the scope of the study, the significance of the study, 
the limitation of the study and outline of each chapter will be discussed.  
1.1 Brief Overview of the World Drug Problem 
United Nations Office on Drugs and Crime (UNODC) estimated that in 2013, 
246 million people or 1 of 20 people between the ages of 15 to 64 years old used an 
illicit drug in 2013 (UNODC, 2015). This is an increase of 3 million users compared 
to the previous year. The use of opiates remained stable and the use of cocaine 
declined, while the use of cannabis and non-medical pharmaceutical opioids 
continued· to rise. Trends in ATS use vary from region to region but South and East 
Asia reported an increase in methamphetamine use. Seizures of ATS continue to rise 
since 2009 where total quantity seized reaching over 144 tons in 2012 and 2013. The 
burden of HIV among people who inject drugs (PWID) continues to be high 
globally. The number of people who require treatment for ATS use is on the rise, but 
the expertise available is still low compared to expertise available for opiate users 
(UNODC, 2015).  
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1.2 Drug Abuse Problem in Malaysia  
From 1980s to around 2003 Malaysia's drug policy was based solely on a 
prohibitionist approach. Non-medical institutional rehabilitation approach was the 
main modality for rehabilitating people who use drugs (PWUD). High relapse rates 
within the first six months of release were reported. Malaysia's failure to reverse an 
increasing trend of HIV infection in the United Nations Millennium Development 
Goal (MDG) prompted the Malaysian government to re-examine its approach 
towards people who use drugs. Figure 1.1 show the number of people who use drugs 
(PWUD) from year 2000 to 2013. These numbers represent people who have been 
certified as drug dependents by the National Anti Drug Agency. While it seems that 
the number of drug dependents detected has been going down from 23,642 people in 
2010 to 7,864 people in 2013 this may be due to the introduction of harm reduction 
programs in 2004. There has been a shift in paradigm on how drug users are viewed 
by the government (section below provides more details). Authorities are not 
arresting drug users as frequently and hence the reduction in the numbers of drug 
users detected (see Figure 1.1). More drug users are now being encouraged to enroll 
in treatment programs. Hence, the number of drug users detected as shown in Figure 
1.1 may not reflect the actual situation of the drug problem in the country. 
 
 
 
 
 
 
 
3 
 
Figure 1.1 Number of people who use drugs (PWUD) detected by the National Anti 
Drug Agency (NADA) from year 2000-2013.  
       
  
Source: National Drug Information System 2013. 
 
Figure 1.2 show the arrest under section 3(1) Drug Dependents (Treatment 
and Rehabilitation) Act, 1983 related to opiate and cannabis drug use from 2006-
2013. There is a general decrease in the number of arrests made for these drugs 
between 2010 (63,466) to 2013 (45,002).  
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Figure 1.2 Arrest under section 3(1) Drug Dependents Act (Treatment and 
Rehabilitation) 1983, related to opiate and cannabis drug use from 2006-2013. 
 
 
   Source: Royal Malaysia Police (2014). 
 
1.3 Classification of ATS Drugs for this Study 
ATS or Amphetamine-Type-Stimulant drugs that are commonly used in 
Malaysia are amphetamine and methamphetamine. Some of the street names used for 
these drugs are syabu and ice. In this study both these drugs will be classified as 
ATS.  
1.4 Trends of ATS in Malaysia 
Malaysia has had a problem traditionally with heroin users and lately in the 
last 8 years there has been a substantial increase in the number of ATS users in the 
country. All ATS users are charged under section 15 (1) of the Dangerous Drug Act. 
The section is for entering drugs into the body.  The reason why police are charging 
these users under this section is because while this drug causes damaging effects it 
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does not show clear physical withdrawal symptoms. For a drug user to be certified a 
drug "dependent" a medical officer has to examine the drug user for symptoms of 
addiction and certify that an individual is a "drug dependent". With this group of 
synthetic drugs, medical officers are unable to observe for these symptoms hence the 
police having no option but to charge these users under section 15(1).  
It is interesting to note that arrests under section 15 (1) (a) which is for using 
ATS and ketamine has been increasing since year 2006. In figure 1.3, the arrests for 
these drugs are almost four-fold where in 2006, 21,653 arrests were made and in 
2013, 85,140 arrests were recorded. This is a sign of increase in the use of ATS in 
the country. These drugs are becoming more prevalent in most parts of the country 
and it has also created a new 'class' of drug users. The socio-demographic 
characteristics of these users are not well established. The data collected by the 
government only provide the number of people who are using ATS but the 
contextual use and other health related consequences are not well understood.  
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Figure 1.3: Arrest under section 15(1)(a) Dangerous Drug Act 1952 (DDA) related 
to Amphetamine-Type-Stimulant (ATS) and Ketamine Drug use from 2006-2013. 
                
 
                                                                                      Source: Royal Malaysia Police (2014). 
Table 1.1 shows the drug seizures in the country between 2011 and 2014.  
Seizures of liquid methamphetamine increased considerably from 76.69kg in 2013 to 
1,260kg in 2014. The seizure of yaba which are metamphetamine and caffeine pills 
also shows an increasing trend from 364,879 pills seized in 2011 to 557,336 pills in 
2014. 
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Table 1.1 Drug Seizures in Malaysia from 2011 to 2014. 
 
Types of Drugs  2011 2012 2013 2014 
Heroin  kg 445.13 362.67 638.61 381.40 
Cannabis  kg 796.05 751.80 539.30 578.19 
Crystal methamphetamine kg 830.29 608.67 1245.63 761.71 
Liquid methamphetamine kg 122.60 27.96 76.69 1,260.09 
Ketamine  kg 106.75 118.07 139.23 216.61 
Amphetamine powder  kg 26.53 457.36 674.62 53.69 
Ecstasy  pills 47,761 634,573 335,984 117,702 
Yaba  pills 364,879 521,384 524,966 557,336 
Erimin 5  pills 87,012 5,175,069 177,916 467,133 
                                                                            Source: Royal Malaysia Police 2015. 
 
1.5 ATS Drugs 
Amphetamine includes S-amphetamine (i.e. d-amphetamine; also referred to 
as dexamphetamine) which is used therapeutically, and racemic amphetamine 
sulphate powder, which is the common form of amphetamine used illicitly in the 
United Kingdom (Cruikshank and Dyer, 2009). Methamphetamine is an indirect 
agonist at dopamine, noradrenaline and serotonin receptors. Due to structural 
similarity, methamphetamine substitutes for monoamines at membrane-bound 
transporters, namely the dopamine transporter (DAT), noradrenaline transporter 
(NET), serotonin transporter (SERT) and vesicular monoamine transporter-2 
(VMAT-2). (Sulzer et al., 2005). Cruikshank and Dyer (2009) published a fairly 
comprehensive review paper on the pharmacology of methamphetamine which also 
includes the effects and significant clinical effects of methamphetamine. McKetin et 
al (2008) provides an Asian regional review on the epidemiological trends of 
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methamphetamine. Both these papers are sufficient to show the effects of ATS and 
how there is a lack of behavioral data on ATS regionally.  
1.6 Brief Overview of Studies Related to ATS Abuse 
ATS abuse is a major problem in many regions of the U.S. Globally, it is now 
the second most commonly used illicit drug type and, along with heroin IDU, 
contributes substantially to HIV transmission in regions where the epidemic is most 
severe, including Malaysia and many other countries in Southeast Asia. Over the past 
decade, laboratories producing ATS have been identified in more than half of the 
countries in the region; large scale laboratories capable of industrial-scale 
manufacture have been found in many of the countries (including China, Malaysia, 
and Indonesia); and an estimated 1% of individuals age 15-64 years in the region 
used ATS in the past year (UNODC, 2009). Surveys of IDUs conducted in a number 
of sites in Malaysia found lifetime ATS use in 57% of heroin IDUs and lifetime 
needle or equipment sharing in 69%; 44% tested positive for HIV; 67% tested 
positive for HCV, and lifetime history of ATS abuse was significantly associated 
with HIV infection (Vicknasingam et al., 2009; Vicknasingam et al., 2009a and 
Vicknasingam et al., 2009b). In another local study by Sulaiman et al (2014) found 
that heavy methamphetamine use was significant with methamphetamine induce 
psychosis. Lim et al (2015) conducted a study among men who have sex with men 
(MSM) and found that ATS use among this population is associated with high risk 
HIV behaviors. 
1.7 Problem Statement 
The National Drug Information System was designed during the heroin 
epidemic.  Drug policies with regard to treatment and rehabilitation were mostly also 
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formulated during the heroin epidemic. Hence, the drug information system and 
policies are more geared to deal with the heroin problem. With the emergence of 
ATS the systems and policies currently available are unable to effectively track, 
monitor and understand the context and patterns of ATS use in the country. This is 
evident where in Figure 1.1 which is the data produced by the National Drug 
Information System, the arrests made by police in Figure 1.3 is not captured to 
reflect the seriousness of ATS use in the country. The police on the other hand 
without much of a choice are charging drug users under section 15(1) which is for 
entering drugs into the body purely because they are unable to charge them under 
section 3(1) which is for heroin use because under this Act a medical officer will 
have to certify that an individual is a drug dependent. Under section 3(1) drug users 
are normally sent for treatment while ATS users charged under section 15(1) can be 
sent to prison and fined. This current situation is not beneficial for those detained 
using ATS since they will not be given the opportunity to enroll in treatment 
programs.  
In addition to this, currently there is no data on the behavioral characteristics 
of ATS drug users in the country. Data on the number of ATS drug users arrested is 
only available and in addition Chawarski et al (2012) conducted a survey among 732 
opiate injecting drug users (IDUs) in Malaysia and found that the cumulative 
proportion of the survey participants initiating heroin use increased steadily 
beginning in the late 1960s. The number of participants initiating ATS use increased 
rapidly after 1997 and by 2008, 75% of the participants had initiated ATS use. More 
important is to understand the context of use in the social environment. With these 
understanding, effective interventions in the form of prevention and treatment 
programs can be put in place.  
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Figure 1.4 Time line of drug use initiation. 
 
 
                                                                                           (Chawarski et al, 2012).  
 
The high cost of these drugs and its stimulants properties may encourage 
users to commit crime to sustain their behavior.  ATS use is also linked to high-risk 
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The link between ATS use and high-risk sexual behavior is also not well established. 
The danger with these drugs is that if it is used for a prolonged period it can cause 
severe mental problems. However, the context of use in relation to high risk behavior 
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Malaysia.  
1.8 Research Questions 
1. What are the socio-demographic characteristics of ATS drug users in 
Malaysia? As from experience in conducting studies with drugs users and 
also from discussions with the police, NGOs and National Anti-Narcotics 
Agency, it was found that the socio demographic characteristics of ATS drug 
users are not well documented. The National Drug Information System 
(NADI) primarily only captures opiate drug users in the system. Currently, 
there are no data to show the socio demographic characteristics of these 
users. These data will be useful as it will be able to have a profile of these 
users in the country.  
2. What are the behavioral characteristics of ATS drug users in Malaysia?  This 
study will specifically attempt to understand the behavioral characteristics of 
these users vis a vis HIV risk behavior. The two main high risk behaviors that 
will be investigated are their drug use practices and sexual behavior. For 
example questions on mode of drug administration, context of drug use, 
frequency of condom use, number of sexual partners, etc will be elicited in 
the survey. 
3. What are the medical health problems or consequences faced by ATS drug 
users in the country? There are evidences to show that ATS drug users have 
higher risks of encountering medical problems as a result of their drug use. 
Specifically, an attempt will be made to understand the mental health 
problems faced by these users. In addition, participants will be asked if they 
have seek treatment for their drug use and also their medical problems.   
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1.9 Objectives of the Study 
1. To identify the socio-demographic characteristics of ATS users in Malaysia. 
2. To understand the context of drug use among ATS drug users in Malaysia. 
3. To identify the sexual behaviors of ATS drug users in Malaysia. 
4. To determine some of the medical health problems linked to ATS use in 
Malaysia.  
1.10 Scope of Study 
This study is aimed at identifying the socio-demographics and behavioral 
characteristics of ATS users in the country. A cross-sectional study design was used 
to collect data among people who reported to use ATS as their primary drug. The 
study was conducted in four states (Penang, Selangor, Kuala Lumpur and Johor) of 
the west coast of peninsular Malaysia.  
1.11 Significance of Study 
Section 1.2, 1.4 and 1.6 provide the background to Malaysian drug problem, 
national data on ATS use in the country and relevant studies that have been 
conducted among ATS users. The national data only shows that number of ATS 
users arrested and does not provide the contextual use and behavioral characteristics 
of ATS users. Studies by Vicknasingam et al (2009, 2009a and 2009b) and 
Chawarski et al (2012) were conducted primarily among opiate drug users. 
Sulaiman et al (2014) studied the psychiatric condition of ATS users who were in 
treatment or in rehabilitation centers. While Lim et al (2015) studied specifically the 
MSM population. To my knowledge, this is the first study that surveyed not in 
treatment primary ATS users in the country. Participants were recruited in the 
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community and were surveyed to obtain their socio-demographics, understand their 
contextual ATS use and also their behavioral characteristics. It is hoped that this 
study will help to better understand the characteristics of ATS users in the country. 
In addition, the data from this study can be used to plan for more effective 
interventions among this group of drug users. Data on the behavioral characteristics 
of ATS users will also be helpful to plan specifically for psychosocial interventions 
since there are currently no effective medications to treat ATS dependence. Perhaps, 
some of the questions in the questionnaire of this study can be adopted and used as 
questions by the National Anti-Drug Agency (NADA) when they are assessing ATS 
users. This will allow NADA to conduct a better assessment and hence come up 
with better interventions for their clients who are assessing their services in the Cure 
and Care Service Centre’s (CCSC) nationwide.  
1.12 Study Limitation 
Drug use is illegal hence drug users normally will use drugs in clandestine 
settings. Drug users are a hidden population where they live among us in society but 
they are difficult to identify. As drug use is illegal, obtaining a population size is not 
possible and using probabilistic sampling techniques is also not possible. This study 
relied on non-probabilistic sampling technique to collect data and this may limit the 
representativeness of study findings. Self-report data collected may also have some 
recall bias weakness and this may affect the accuracy of the data. Measures were 
taken to only conduct the survey among current users where recall bias is minimized. 
Self-report of participants experiences with regard to their health problems may be 
compounded by problems that may have arisen from other non-drug use medical 
conditions or consequences from other drugs (non ATS). Since there were no clinical 
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examinations or tests conducted we are unable to objectively determine the accuracy 
of these self-reported medical consequences of ATS use. These self-reported 
findings are however discussed with other published literature to corroborate the 
findings.  
1.13 Thesis Presentation 
The thesis consists of six chapters. The first chapter is the introduction 
chapter of the thesis where the topic of the study is introduced and a brief literature 
review is provided to give the reader an overall idea to the thesis. The brief literature 
review will also justify why this study is important to be undertaken and hence a 
section on the statement of problem justifying the conduct of this study. This is 
followed by the research questions that this study is set out to do and what are the 
objectives that this study hopes to achieve. The scope of the study is also described 
in this chapter and the significance or what is the contribution of this study is 
explained. The study limitation is also in the first chapter to provide the reader with 
an understanding of what the constraints were in terms of the study design as well as 
the limitation encountered during the implementation of the study.  
The second chapter of the thesis is the literature review chapter. In this 
chapter, the world drug problem and the Malaysian drug problem with an emphasis 
to amphetamine type stimulants (ATS) is discussed. This is followed by what is and 
also the classification of ATS. A brief discussion on the pharmacology of ATS, its 
effects on humans and linking the various concepts of drug use disorders to ATS is 
discussed in this chapter. A review of the behavioral characteristics of ATS use from 
the various studies conducted is also useful to understand and also helped design the 
questionnaire for this study.  
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The third chapter consists of the methods used in this study. The study design 
used and the justification for its use are discussed. The sample, sample size and how 
the samples or study participants were recruited are all described in detail. The 
inclusion and exclusion criteria of the study participants are listed. The study 
instrument used in this study and the various sections in this instrument as well as the 
source of where some questions were obtained are detailed. The implementation of 
the study using survey techniques and specific locations where data was collected is 
also presented here. Procedures how urine specimens were collected and the types of 
illicit drugs that participants were tested for are listed. The ethical issues and 
potential risks for taking part in this study as well as compensation for taking part in 
this study is all described clearly in this chapter. Finally, how the collected data was 
managed and analyzed are explained here.  
Chapter four is the results of the study. This chapter is divided mainly into 
two main parts where the first part describes the frequency of the data. In this first 
part, the socio-demographics of the participants, urine drug toxicology screen 
results, drug use and other behavioral characteristics of the participants are 
presented in frequency tables. This is followed by the health consequences of ATS 
use. Statements using a likert scale to measure physical and psychological 
symptoms, intensity of craving for ATS and the motivation to change are also 
described using frequency tables in the first part of this chapter. In the second part 
of this chapter, secondary analysis looking at variables that are significant are 
presented and discussed.  
Chapter five is the discussion chapter where all the study results are 
discussed. The format of discussion in this chapter is done with regard to the 
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objectives of this study. The results are discussed with the relevant literature to 
highlight the importance of the results and to also show if the findings of this study 
are similar or different to other studies.  
The last chapter is the conclusion chapter where all the results are 
summarized and concluded. The implication of this study and the lessons learnt are 
discussed in this chapter for the benefit of other researchers.  
1.14 Conclusion 
The first chapter of the thesis provides an overview to highlight the 
importance of conducting this study. Based on this the research questions and 
objectives of this study is described in this chapter. More extensive discussion on the 
drug problem in the world and the country as well as discussion on the extent of 
ATS use and its dangers are discussed in chapter two of the thesis. 
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CHAPTER 2 
 
LITERATURE REVIEW 
2.0 Introduction 
This chapter will discuss all the relevant literature with regard to this thesis. 
Some of the earlier sections in this chapter will be repetitive topics from chapter 1, but in 
this chapter a more in-depth discussion with the literature will be done to ensure all 
relevant and current literature are discussed.    
2.1 World Drug Problem 
In 2013, an estimated a quarter million people with a global prevalence of 5.2% 
have used an illicit drug (UNODC, 2015). While the absolute number of drug users has 
increased this has also corresponded with the increase in the world’s population hence 
this increase is considered stable and this has been the trend over the last three years. In 
terms of types of drugs used, cannabis use continues to rise globally since 2009, but the 
use of opioids which includes heroin, opium are stable. Overall, the use of cocaine and 
amphetamines has declined but this is mainly due to the trends reflected in Americas and 
Europe. In the section below, a closer look at the trends in Asia will provide a better 
picture to the problem of ATS use in Malaysia.     
The burden of HIV among people who inject drugs (PWID) continues to be high 
globally with a prevalence of 13.5%. By region, Europe has the highest prevalence 
(12.6%) mainly because of Eastern Europe, followed by Asia (12.6%), Africa (11.2%), 
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America (8.4%) and Oceania (1.0%). The figures are more alarming for hepatitis C, 
where every other person who injects drugs is living with hepatitis C (UNODC, 2015). 
Worldwide, deaths among drug users are primarily related to drug overdose. It is 
estimated that 187,100 were drug related deaths in 2013. Specifically, heroin related 
overdose has increased exponentially from 3,036 in 2010 to 8,527 in 2013 (Hedegaard et 
al., 2015).     
2.2 Amphetamine Type Stimulants (ATS) Problem in Asia  
ATS drugs have joined opioids and cannabis as the most commonly drugs 
misused in the world today (UNODC, 2015). Southeast and East Asia have emerged as 
the main drug producing and trafficking centre of the world in the last decade (UNODC, 
2007, Kozel et al., 2006 and Kozel et al., 2007). In the last two decades, ATS and 
ketamine use have increased tremendously and providing treatment for these groups of 
users continues to be a challenge. Methamphetamine is available in crystalline and tablet 
form. The crystalline form is reported to be more potent. It is estimated that more than 
half of the world’s ATS users reside in Asia (UNODC, 2007). ATS dominates the 
synthetic drug market in Asia. United Nations Office on Drugs and Crime (UNODC) 
estimates that in Asia and Oceania there are 9.5 million methamphetamine users and 
another 3.9 million ecstasy users. In Asia and Oceania seizures of ATS have increased 
from 12 tons in 2008 to 48 tons in 2013 (UNODC, 2015a).  
China, Cambodia, Brunei, Singapore, Vietnam, Philippines and Korea recorded 
an increase in the use of crystalline methamphetamine in 2013. While, 
methamphetamine tablets increased in Cambodia, China, Myanmar, Vietnam, Thailand 
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and Laos during the same period (UNODC, 2015a). Methamphetamine users receiving 
treatment is also increasing in the region. China, Philippines and Myanmar recorded an 
increase in the number of people receiving treatment (Drug Abuse Information Network 
for Asia and the Pacific, 2014). Providing effective treatment for ATS users is still a 
challenge. There are no approved pharmacological interventions available to treat ATS 
users and only psychosocial interventions are available. Well developed treatment 
protocols in the region are still in need and while more ATS users are in need of the 
treatment, the quality of treatment provided cannot be ascertained regionally.  
Obtaining good data in the region is still a challenge. Only seizure of ATS data is 
available, drug arrests and treatment data is not collected systematically and routinely in 
the region. Only a few countries conduct nationally representative household surveys to 
understand the trends of ATS use (McKetin et al., 2008). There is also an emerging 
problem of poly-drug use among ATS users. The number of drug users who are using 
opioids and other New Psychoactive Substances (NPS) together with ATS is not well 
understood in the region.          
2.3 Malaysian Drug Problem 
The data to describe the Malaysia drug problem will be divided into three main 
sections. First the number of drug users detected and/or detained will be shown, 
followed by the number of drug dependents who are in treatment, followed by 
enforcement data on the seizures of drugs as well as the number of suspected drug 
traffickers detained. It is important to examine these various types of data to gain a 
better insight to the drug problem in the country. A total of 413,754 registered drug users 
